Australian Trachoma Surveillance Report 2014

List of Figures

Page last updated: 30 October 2015

Figure 1.1 Trachoma prevalence in children aged 5-9 years in at-risk communities in Australia, 2014

Figure 1.2 Number of communities at-risk by year and jurisdiction, Australia, 2007 – 2014

Figure 1.3 Number of at-risk communities by jurisdiction, according to trachoma control strategy implemented, Australia, 2014

Figure 1.4 Population screening coverage in communities that were screened for trachoma by jurisdiction, Australia, 2014

Figure 1.5 Proportion of screened children aged 5-9 years who had a clean face by year and jurisdiction, Australia, 2007-2014

Figure 1.6a Observed trachoma prevalence among screened children aged 5-9 years, by year and jurisdiction, Australia, 2007-2014

Figure 1.6b Trachoma prevalence among screened children aged 5-9 years, by year and jurisdiction, Australia*, 2007-2014.

Figure 1.7 Number of screened at‑risk communities according to level of trachoma prevalence in 5‑9‑year‑old children, by jurisdiction, Australia, 2014

Figure 1.8 Number of communities according to number of years of trachoma prevalence under 5%, by jurisdiction in Australia, 2014

Figure 1.9 Number of doses of azithromycin administered for the treatment of trachoma by Jurisdiction in Australia, 2007-2014

Figure 2.1 Trachoma prevalence in children aged 5-9 years, number of communities that were screened treated or both for trachoma and number of at-risk communities in the Northern Territory, 2014

Figure 2.2 Number of communities at-risk by region in the Northern Territory, 2007-2014

Figure 2.3 Number of at-risk communities by region, according to trachoma control strategy implemented, Northern Territory 2014

Figure 2.4 Population screening coverage in communities that required screening for trachoma by region in the Northern Territory, 2014

Figure 2.5 Proportion of screened children aged 5-9 years who had a clean face by region in the Northern Territory, 2007-2014

Figure 2.6a Trachoma prevalence among children aged 5-9 years in communities that were screened by region in the Northern Territory, 2007-2014

Figure 2.6b Trachoma prevalence among children aged 5-9 years by region in the Northern Territory with projected values, 2007-2014

Figure 2.7 Number of at-risk communities according to level of trachoma prevalence in 5-9-year-old children in 2014, by region in the Northern Territory

Figure 2.8 Communities according to number of years of trachoma prevalence under 5% by Northern Territory Region, 2014

Figure 2.9 Number of doses of azithromycin administered for the treatment of trachoma by Northern Territory region, 2007-2014

Figure 3.1 Trachoma prevalence in children aged 5-9 years, number of communities that were screened treated or both for trachoma and number of at-risk communities in South Australia, 2014

Figure 3.2 Number of communities at-risk by region in South Australia, 2007-2014

Figure 3.3 Number of at-risk communities by region, according to trachoma control strategy implemented, South Australia, 2014

Figure 3.4 Population screening coverage in at-risk communities that required screening for trachoma by region in South Australia in 2014

Figure 3.5 Proportion of screened children* aged 5-9 years who had a clean face by region in South Australia, 2007-2014

Figure 3.6 Trachoma prevalence among children aged 5-9 year in at-risk communities that were screened by region in South Australia, 2007-2014

Figure 3.7 Number of at‑risk communities according to level of trachoma prevalence in children aged 5-9, by region, South Australia, 2014

Figure 3.8 At‑risk communities according to number of years of trachoma prevalence under 5%, by region, South Australia, 2014

Figure 3.9 Number of doses of azithromycin administered for the treatment of trachoma by South Australian region, 2007-2014

Figure 4.1 Trachoma prevalence in children aged 5-9 years, number of communities that were screened treated or both for trachoma and number of at-risk communities in Western Australia, 2014

Figure 4.2 Number of communities at-risk by region in Western Australia, 2007-2014

Figure 4.3 Number of at-risk communities by region, according to trachoma control strategy implemented, Western Australia, 2014

Figure 4.4 Population screening coverage in children aged 5‑9 years in communities that required screening for trachoma, by region, Western Australia, 2014

Figure 4.5 Proportion of screened children aged 5-9 years who had a clean face by region in Western Australia, 2007-2014

Figure 4.6a Trachoma prevalence among children aged 5‑9 years in communities that were screened, by region, Western Australia, 2007-2014

Figure 4.6b Trachoma prevalence among children aged 5‑9 years, by region, Western Australia with projected values, 2007-2014

Figure 4.7 Number of at‑risk communities according to level of trachoma prevalence in children aged 5-9, by region, Western Australia, 2014

Figure 4.8 Communities according to number of years of trachoma prevalence under 5%, by region, Western Australia, 2014

Figure 4.9 Number of doses of azithromycin administered for the treatment of trachoma by Western Australia region, 2007-2014

Figure 5.1 Trachoma prevalence in children aged 5-9 years, number of communities that were screened treated or both for trachoma and number of potentially at-risk communities in NSW, 2014

Appendix Figures

Figure A.1 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in North Alice Springs Remote region, Northern Territory, 2007-2014

Figure A.2 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in South Alice Springs Remote region, Northern Territory, 2007-2014

Figure A.3 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in Barkly region, Northern Territory, 2007-2014

Figure A.4 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in Darwin Rural region, Northern Territory, 2007-2014

Figure A.5 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in East Arnhem region, Northern Territory, 2007-2014

Figure A.6 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in Katherine region, Northern Territory, 2007-2014

Figure A.7 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in APY Lands region, South Australia, 2007-2014

Figure A.8 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in Eyre and Western region, South Australia, 2007-2014

Figure A.9 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in Goldfields region, Western Australia, 2014

Figure A.10 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in West Kimberly region, Western Australia, 2014

Figure A.11 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in East Kimberly region, Western Australia, 2014

Figure A.12 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in Midwest region, Western Australia, 2014

Figure A.13 Trachoma prevalence of screened children aged 5‑9 years by year and de‑identified community in Pilbara region, Western Australia, 2007-2014

Top of page